siRNA treatment decreases triglycerides in clients with unusual condition
.RESEARCH EMPHASIZE.19 September 2024.
Plozasiran lessened triglyceride levels through 80% as well as reduced the danger of pancreatitis in patients with persistent chylomicronemia, along with or even without a genetic prognosis.